Oppenheimer Downgrades Sunesis Pharmaceuticals Inc. (SNSS) to Perform
Tweet Send to a Friend
Oppenheimer analyst Hartaj Singh downgraded Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS) from Outperform to Perform.The analyst commented, "On 06/23, Sunesis (SNSS) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
